You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仙琚製藥(002332.SZ):米非司酮片通過一致性評價
格隆匯 03-09 15:57

格隆匯3月9日丨仙琚製藥(002332.SZ)公佈,公司於近日收到國家藥品監督管理局核准簽發的關於米非司酮片的《藥品補充申請批准通知書》(通知書編號:2023B009922023B00993),公司米非司酮片通過仿製藥質量和療效一致性評價。

公司25mg米非司酮片的批准文號有:國藥準字H10950347、國藥準字H20000649。國藥準字H10950347,商品名:含珠停,用於終止宮內妊娠;國藥準字H20000649,商品名:後定諾,用於緊急避孕。目前產品執行藥品註冊標準YBH03062023。

米非司酮是一種孕酮受體水平的抗孕激素,具明顯抗黃體、抗着牀、抗排卵與誘導月經作用,也可影響孕卵運行。本品無明顯抗雌激素作用,也無雌激素和雄激素樣活性,與糖皮質激素受體也有一定結合能力,具有一定的抗糖皮質激素作用。國內外米非司酮主要被批准用於終止宮內妊娠、庫欣綜合症、緊急避孕和子宮內膜異位症。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account